Evidence map›Paper›PMID 39553442›Full record

ArticleTremor and other hyperkinetic movements (New York, N.Y.)2024

Echography-guided Botulinum Toxin for Moving Ear Syndrome.

Vidal Yahya, Rosa Consuelo Chavez, Laura Campiglio, Manuela Zardoni, Alberto Priori

Abstract readCase ReportsVideo-Audio Media
In one paragraph

Article in Tremor and other hyperkinetic movements (New York, N.Y.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Vidal YahyaAldo Ravelli Center for Neurotechnology and Experimental Brain Therapeutics, Department of Health Sciences, University of Milan, Milan, Italy.
Rosa Consuelo ChavezAldo Ravelli Center for Neurotechnology and Experimental Brain Therapeutics, Department of Health Sciences, University of Milan, Milan, Italy.
Laura CampiglioClinical Neurology Unit, ASST Santi Paolo e Carlo, San Paolo University Hospital Milan, Italy.ORCID 0000-0002-1556-0727
Manuela ZardoniClinical Neurology Unit, ASST Santi Paolo e Carlo, San Paolo University Hospital Milan, Italy.
Alberto PrioriAldo Ravelli Center for Neurotechnology and Experimental Brain Therapeutics, Department of Health Sciences, University of Milan, Milan, Italy.ORCID 0000-0002-1549-3851

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Moving Ear Syndrome is a rare hyperkinetic disorder. Phenomenology shown: This Video Abstract illustrates typical backward movements of the right ear associated with pain and discomfort in a man with Moving Ear Syndrome. Educational value: Moving Ear Syndrome is effectively and safely treatable with EMG-US-guided botulinum toxin injections.

Indexed as

Botulinum Toxins, Type ABotulinum ToxinsEarElectromyographyHumansMaleMiddle AgedNeuromuscular AgentsSyndromeUltrasonographyUltrasonography, InterventionalBotulinum ToxinsBotulinum Toxins, Type ANeuromuscular Agentsbotulinum toxindystoniamoving ear syndromephenomenologytic

Identifiers

PMID39553442
PMCPMC11568798

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.